Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-05 @ 5:34 PM
Study NCT ID:
NCT05579366
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2022-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor:
Genmab
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-04
First Submit QC Date:
None
Study First Post Date:
2022-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-01
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED